Indeed, microtubule stabilizing agents were shown to suppress tau-mediated axonal dysfunction, neurotoxicity and cognitive deficits on in vivo models, which suggested the possible therapeutic potential of these anti-cancer agents in Alzheimer’s disease [77,78]. This evidence concerns the gene MAPT and Alzheimer disease.